Fundraising FoxMatrix Capital Management
Venture capitalPortsmouth · 4 people tracked
Find your way into Matrix Capital Management
Each arrow is one introduction. Sign up to fill in the first one.
Ask Rana Al-Hallaq to introduce you to Andy Tran
You →Rana · together at ReCode Therapeutics →Andy
Ask Jamie Chen to introduce you to Slava Darkhaev
You →Jamie · together at Matrix Capital →Slava
Ask Sam Okafor to introduce you to Dmitry Alpatkin
You →Sam · together at Matrix Capital →Dmitry
- David Goel2 people can intro you
Sign up to find every way you can get introduced to Matrix Capital Management
- Your email: who you already know at Matrix Capital Management, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Matrix Capital Management team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Team · 4 people
from public directoriesWhat they invest in
from 10 of 11 portfolio companiesBiotech ×8AI & Machine Learning ×4Digital Health ×4Healthtech ×4Deep Tech ×2Enterprise Software ×2Medical Devices ×2Crypto & Web3 ×1
HQs:United States×10
Investments · 11 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12021 · 32020 · 22015 · 29 dated
Maze Therapeutics develops precision medicines for common diseases with high unmet need, using its Compass platform based on human genetics and variant functionalization.
AI & Machine LearningBiotechSouth San Francisco, US
Charles Homcy(Director)Jason Coloma(Chief Executive Officer)in
Co-investorsAndreessen HorowitzARCH Venture PartnersForesite CapitalFrazier Life SciencesGV (Google Ventures)Hercules Capital, Inc.+9 more
Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms.
BiotechDigital HealthMedical DevicesWaltham, US
James W. Broderick(Executive Officer, Director)Jim Broderick(Co-Founder)John Hennessy(Executive Officer)Karen Hong(Director)James Lee(Director)Stephen Hoffman(Director)
Co-investorsPfizer VenturesPfizer Venture InvestmentsSR One Capital ManagementBioHealth Innovation, Inc.Takeda VenturesVertex Ventures HC
Solve Therapeutics is a clinical-stage oncology biotech developing antibody-drug conjugates (ADCs) and radiopharmaceuticals for solid tumors, built around its CloakLink hydrophilic cleavable linker platform and an integrated diagnostic for patient selection.
BiotechDeep TechHealthtech
David Johnson(Chief Executive Officer)Clayton Knox(President)Katti Jessen(SVP, Translational Sciences)Yakov Kogan(Head of Operations)Brian Lannutti(Research & Development Leadership)Langdon Miller(Clinical Development Leadership)
Co-investorsDecheng CapitalYosemiteB Capital GroupB4 Capital
.jpeg){kind=logo}
Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making.
AI & Machine LearningBiotechDigital HealthMedical DevicesCambridge, US
Murali Aravamudan(Executive Chairman of the Board; co-founder of nference)inMaulik Nanavaty(Chief Executive Officer)inHarris Fishman(Executive Officer)Alan Colowick(Director)Cheranjit Rihal(Director)David Goel(Director)
Co-investorsNTT Venture CapitalMatrix
Bardavon Health Innovations provides clinical case management and care coordination services for injured workers in the workers' compensation space, guiding them through recovery and return-to-work processes.
Digital HealthEnterprise SoftwareHealthtechInsurTechOverland Park, US
Matthew Condon(CEO (until early 2024))inJeff Hogland(Executive Officer, Director)Paul Morris(Executive Officer, Director)in
BoardRobert K Green(Director)Matthew Ferguson(Director)
Co-investorsCobalt VenturesKCRise FundNewRoad Capital Partners, LLC
Blockdaemon provides blockchain infrastructure services including staking, node deployment, APIs, and wallet management across 60+ protocols for financial institutions and developers.
Crypto & Web3Data & InfrastructureEnergyEnterprise SoftwareFintechLos Angeles, US
Konstantin Richter(CEO and Founder)in
BoardEd Sim(Director)inGil Beyda(Director)in
Co-investors10SQ Capital (TenSquared)Amplify.LAAurum Venture PartnersBaroda VenturesBlockchain Coinvestorsboldstart ventures+31 more
Santa Clara-based provider of advanced threat protection software for detecting next-generation malware.
Santa Clara, US
Manoj Leelanivas(Executive Officer, Director)
Co-investorsClear VenturesDell Technologies CapitalSapphire VenturesZouk CapitalFoundation CapitalMatrix+1 more
Encoded develops gene therapies for neurological disorders through an integrated platform approach.
BiotechSouth San Francisco, US
Stephanie Tagliatela(Co-founder, Chief Scientific Officer & Board Member)inKartik Ramamoorthi, Ph.D.(Co-founder, Chief Executive Officer & Board Member)
Co-investorsARCH Venture PartnersBioBritGV (Google Ventures)Illumina VenturesMenlo VenturesSoftBank Vision Fund+2 more
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)
Co-investorsDelos CapitalVivo CapitalAMR Action FundBoehringer Ingelheim Venture FundKorea Investment PartnersLilly Asia Ventures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EpiBiomePredible Health
Exits · 3
1 IPOs · 2 acquisitions · showing 2Maze TherapeuticsNASDAQ: MAZEPredible Healthacq. by nference
Portfolio news
latest coverage across their companies
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed May 2005
Files 13F institutional holdings reports · latest Aug 2007
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Matrix Capital Management made?
- Matrix Capital Management has 11 tracked investments, 3 of which have exited, including 2 dated in the last 24 months.
- What sectors does Matrix Capital Management focus on?
- Matrix Capital Management focuses on Crypto & Web3.
- Where is Matrix Capital Management located?
- Matrix Capital Management is headquartered in Portsmouth, US.
Co-investors · 6
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
SignalFire is a seed-stage venture capital firm that combines a full-team support model with its data-driven Beacon AI platform to back founders.
Gradient is a seed-stage venture fund focused on backing founders building artificial intelligence companies, providing hands-on support as builders and mentors.
Base10 Partners is a venture capital firm investing in automation technologies for the real economy, backing companies that solve problems for the '99%'. The firm donates a portion of its proceeds to support the next generation of technology founders.
Flashpoint is a technology investment firm that backs tech founders throughout their journey via venture growth equity, growth debt, and secondary transactions.
Firms observed investing alongside Matrix Capital Management, from public investor directories. Shared companies are the overlap with Matrix Capital Management's recorded portfolio.
Similar investors
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.